Overt hepatic encephalopathy: development of a novel clinician reported outcome tool and electronic caregiver diary

• Published in: Metabolic brain disease Vol. 31; no. 5; pp. 1081 - 1093
• Main Authors: Bajaj, J. S., Frederick, R. T., Bass, N. M., Ghabril, M., Coyne, K., Margolis, M. K., Santoro, M., Coakley, D. F., Mokhtarani, M., Jurek, M., Scharschmidt, B. F.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.10.2016; Springer Nature B.V
• Subjects: Aged; Biochemistry; Biomedical and Life Sciences; Biomedicine; Caregivers - psychology; Caregivers - trends; Delphi Technique; Electronic Health Records - trends; Female; Hepatic Encephalopathy - diagnosis; Hepatic Encephalopathy - psychology; Humans; Male; Medical Records; Metabolic Diseases; Middle Aged; Neurology; Neurosciences; Oncology; Original Article; Physicians - trends; Treatment Outcome; Cirrhosis; Clinical trial; Liver failure; Altered mental status; Chronic liver disease
• ISSN: 0885-7490; 1573-7365
• DOI: 10.1007/s11011-016-9851-9

Clinical management and clinical trials of patients with overt hepatic encephalopathy (OHE) are compromised by lack of standardized and reproducible tools for its clinical diagnosis or for caregiver (CG) identification of OHE manifestations which merit medical evaluation. Using an iterative Delphi method, Steering Committee and international hepatologist panel, the West Haven (WH) scale was modified to develop and operationalize a clinician tool for OHE identification and grading (HE Grading Instrument, HEGI™). Major diagnostic criteria included disorientation to time, place, and person, asterixis, lethargy, and coma. Minimum HEGI requirements for OHE diagnosis included: (1) disorientation, or (2) presence of both lethargy and asterixis, or (3) coma. Inter- and intra-rater HEGI reproducibility were 97 % and 98 %, respectively. When applied to a phase II clinical trial population of 178 patients with 388 OHE episodes, HEGI demonstrated excellent concordance with investigator judgement. Additionally, a multi-stage study was conducted to develop a daily CG e-diary, based on OHE manifestations recognizable by CG including speech difficulties, unusual behavior, forgetfulness, confusion, disorientation and level of consciousness. The e-diary was designed for use on smart phone, laptop or desktop, utilized branching logic and skip patterns, incorporated automatic daily completion reminders and real time alerts to clinical sites to facilitate daily standardized CG input and was found to be user friendly and understandable. The HEGI and e-diary, which were developed using methodology accepted by regulatory authorities, are designed to facilitate the design and interpretation of clinical trials for OHE and improve outcomes for OHE patients in clinical practice.